These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 910999

  • 1. Maintenance antipsychotic dosage and tardive dyskinesia.
    Solomon K.
    Am J Psychiatry; 1977 Nov; 134(11):1314-5. PubMed ID: 910999
    [No Abstract] [Full Text] [Related]

  • 2. Masking of tardive dyskinesia with four times-a-day administration of chlorpromazine.
    Jeste DV, Olgiati SG, Ghali AY.
    Dis Nerv Syst; 1977 Sep; 38(9):755-8. PubMed ID: 902564
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [Abstract] [Full Text] [Related]

  • 5. Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.
    Khorana AB, Patel Y.
    Indian J Physiol Pharmacol; 1988 Apr; 32(4):293-8. PubMed ID: 3063660
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [For how long should antipsychotic medication be continued after the first psychotic episode in schizophrenics?].
    van Harten PN, Hoek HW.
    Ned Tijdschr Geneeskd; 1998 Jun 13; 142(24):1361-4. PubMed ID: 9752021
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prevention of tardive dyskinesias].
    Herrero Velasco L, Montero Vilanova R.
    Med Clin (Barc); 1985 Feb 23; 84(7):293-4. PubMed ID: 2858610
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prevention of tardive dyskinesia caused by neuroleptic therapy].
    Perényi A.
    Orv Hetil; 1981 Jul 05; 122(27):1627-30. PubMed ID: 6117046
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C, Seeman MV, Seeman P.
    J Clin Psychiatry; 1981 Jan 05; 42(1):16-22. PubMed ID: 6109715
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM, Yu SC, Lin CC.
    J Clin Psychiatry; 2003 Nov 05; 64(11):1342-8. PubMed ID: 14658949
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.